Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MYRIAD GENETICS INC | 132,141 | reported | 05 Jun 2025 | tx 8+138,341−6,200 |
| Coherus Oncology, Inc. | 112,000 | reported | 12 Jun 2025 | tx 4+316,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | MYRIAD GENETICS INC | 49,796 | 0.00 USD | |
| 06 Jun 2024 | GRANT_AWARD | MYRIAD GENETICS INC | 15,695 | 0.00 USD | |
| 03 Jun 2024 | GRANT_AWARD | Coherus Oncology, Inc. | 112,000 | 0.00 USD | deriv |
| 13 May 2024 | SALE | MYRIAD GENETICS INC | 6,200 | 25.30 USD | |
| 07 Jun 2023 | GRANT_AWARD | Coherus Oncology, Inc. | 38,250 | 0.00 USD | deriv |
| 01 Jun 2023 | GRANT_AWARD | MYRIAD GENETICS INC | 15,151 | 0.00 USD | |
| 02 Jun 2022 | GRANT_AWARD | MYRIAD GENETICS INC | 17,275 | 0.00 USD | |
| 02 Feb 2022 | GRANT_AWARD | Coherus Oncology, Inc. | 54,000 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | MYRIAD GENETICS INC | 12,848 | 0.00 USD | |
| 04 Dec 2020 | GRANT_AWARD | MYRIAD GENETICS INC | 15,889 | 0.00 USD | |
| 05 Dec 2019 | GRANT_AWARD | MYRIAD GENETICS INC | 11,687 | 0.00 USD |